Patent · US Active

Soluble estradiol capsule for vaginal insertion

US10888516B2 · kind B2 · utility

11Cited by
585References
19Claims
0Family size

Assignee

Inventors

Key dates

Filing dateMar 27, 2020
Grant dateJan 12, 2021
Priority date
Expiry dateMar 27, 2040

Classification

  • Technology area (CPC A)Human Necessities
  • CPC primaryA61K47/44
  • WIPO fieldPharmaceuticals
  • WIPO sectorChemistry

Abstract

According to various embodiments of this disclosure, pharmaceutical formulations comprising solubilized estradiol are provided. In various embodiments, such formulations are encapsulated in soft capsules which may be vaginally inserted for the treatment of vulvovaginal atrophy.

Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.